BTOG - British Thoracic Oncology Group


The British Thoracic Oncology Group (BTOG) is the multi-disciplinary group for healthcare professionals involved with thoracic malignancies throughout the UK. BTOG's mission is to To support and educate thoracic oncology healthcare professionals, creating a professional community to exchange ideas, information and innovation and to foster the development of research. The overall aim is to represent the needs of people with thoracic malignancies in the UK and ensure they have equitable access to optimal care. Find out more here - https://www.btog.org/
BTOG Podcast Series: BTOG does Diagnosis and Staging with Dr Neal NavaniBTOG Podcast Series: BTOG does EGFR mutated lung cancer with Professor Samreen AhmedBTOG Essential Update: Supporting Patients with Thoracic MalignanciesBTOG Masterclass: Leading Your Lung Cancer PathwayBTOG webinar - Advanced RT Techniques: Tips and Tricks for Challenging CasesBTOG webinar: WCLC 2021and ESMO 2021 in an HourBTOG Masterclass: Peri-Operative Therapies July 2021On Demand: BTOG Webinar: Mesothelioma Essential UpdateBTOG Surgical Webinar: Controversies in the Management of Early Stage Lung Cancer
BTOG Surgical Webinar – Controversies in the Management of Early-Stage Lung Cancer Thursday 25th March 2021 Biographies Kelvin Lau Consultant Thoracic Surgeon, London I am consultant and lead thoracic surgeon at St Bartholomew’s Hospital, London. I qualified from the University of Oxford in 2002. During my time at Oxford I was awarded a ICRF scholarship to investigate molecular angiogenesis and vascular targeting of anti-cancer treatment at the Institute of Molecular Medicine for which I was awarded a doctorate of philosophy. After my training, I obtained his membership in 2005, and was awarded the only cardiothoracic surgery national training number in 2006. I received my training in Glenfield Hospital, Nottingham and London, and went on to complete a minimally invasive thoracic surgery fellowship at the Chinese University of Hong Kong where I was then made honorary assistant professor. On return to the UK in 2013, I was appointed as the first consultant thoracic surgeon for St Bartholomew’s Hospital where I set up the thoracic surgery service, introduced VATS lobectomy and endobronchial programmes, and recently, one of the first dedicated 24/7 cardiothoracic robotic surgery programme in the UK. In November 2015, I led the first team in Europe to successfully use the latest version of navigation bronchoscopy and went on to do the first in the world endobronchial microwave ablation of lung tumour in February 2018. Robert Stevenson Consultant Clinical Oncologist, Birmingham Dr Stevenson qualified from the University of Warwick in 2005. He trained within the West Midlands and was appointed as Consultant Clinical Oncologist at University Hospitals Birmingham in 2014. Dr Stevenson is also a visiting consultant to Sandwell and West Birmingham Hospitals NHS Trust and Heart of England NHS trust. Dr Stevenson specialises in the treatment of lung and urological cancers with chemotherapy, hormonal therapy and radiotherapy. Dr Stevenson is also involved in 4-dimensional and stereotactic lung radiotherapy within Birmingham and has experience in delivering Cyberknife treatment to an early stage of lung cancer. Dr Stevenson has published papers in peer-reviewed journals and is the principal investigator (PI) for a number of national clinical trials. Malcolm Will Consultant Thoracic Surgeon, The Royal Infirmary of Edinburgh. Specialist interest in minimally invasive thoracic surgery, airway diseases, chest wall disorders and interventions for COPD
Mar 31 2021
43 mins
WCLC20 in an Hour - BTOG WebinarOn Demand: Molecular Sub-types Beyond EGFR, ALK, ROS BTOG MasterclassBTOG Masterclass: Stage III NSCLCBTOG Masterclass: Diagnosing Lung CancerLung Cancer in the time of COVID - BTOG WebinarOn Demand: ESMO 2020 in an Hour - BTOG WebinarOn-demand: WCLC 2020 Virtual Presidential Symposium Abstracts in an Hour - BTOG Webinar
Exploring studies and advances in thoracic oncology showcased at the IASLC WCLC 2020 Virtual Presidential Symposium on 8th August and the potential implications on UK practice. View on demand at btogwebinars.org   Programme Chair: Professor Sanjay Popat The faculty will disseminate the trial data presented, discuss in UK context, and take questions. ORIENT-11 Alastair Greystoke Abstract 1: ORIENT-11: Sintilimab + Pemetrexed + Platinum as First-Line Therapy for Locally Advanced or Metastatic Non-Squamous NSCLC (Speaker: Zhang Li, China) eXalt3 Fiona Blackhall Abstract 2: Phase 3 Randomized Study of Ensartinib vs Crizotinib in Anaplastic Lymphoma Kinase (ALK)–Positive NSCLC Patients: eXalt3 (Speaker: Leora Horn, USA) CheckMate-743 Riyaz Shah Abstract 3: First-Line Nivolumab + Ipilimumab vs Chemotherapy in Unresectable Malignant Pleural Mesothelioma: CheckMate 743 (Speaker: Paul Baas, Netherlands)   Faculty Professor Sanjay Popat is Consultant Thoracic Medical Oncologist at the Royal Marsden Hospital and Professor of Thoracic Oncology at the Institute of Cancer Research and Chair of the BTOG Steering Committee Dr Alastair Greystoke is Clinical Senior Lecturer and Honorary Consultant at the Newcastle University and the Northern Centre for Cancer Care Professor Fiona Blackhall is Professor of Thoracic Oncology and Honorary Consultant in Medical Oncology at the Christie NHS Foundation Trust Dr Riyaz Shah is a Consultant Medical Oncologist at Kent Oncology Centre, Maidstone and Tunbridge Wells NHS Trust
Oct 15 2020
1 hr 3 mins
ASCO in an hour - BTOG Webinar